BMRN BioMarin Pharmaceutical Inc.
Healthcare$52.88-2.24%ClosedMarket Cap: $10.22B
As of 2026-05-26
Analyst Consensus
Consensus
Buy
Target (Consensus)
$89.93
Target (Median)
$95.00
Target Range
$50.00 - $120.00
Upside from current price: 70.1%
Rating Distribution
5 Strong Buy15 Buy6 Hold0 Sell0 Strong Sell
Recent Analyst Ratings
| Date | Firm | Action | Rating | Previous |
|---|---|---|---|---|
| 2026-05-22 | Canaccord Genuity | maintain | Buy | Buy |
| 2026-05-19 | B of A Securities | maintain | Buy | Buy |
| 2026-05-18 | HC Wainwright & Co. | maintain | Neutral | Neutral |
| 2026-05-05 | RBC Capital | maintain | Sector Perform | Sector Perform |
| 2026-05-05 | Morgan Stanley | maintain | Overweight | Overweight |
| 2026-05-05 | Evercore ISI Group | maintain | Outperform | Outperform |
| 2026-05-05 | Bernstein | maintain | Outperform | Outperform |
| 2026-03-11 | B of A Securities | maintain | Buy | Buy |
| 2026-03-04 | Barclays | maintain | Overweight | Overweight |
| 2026-03-02 | Freedom Broker | maintain | Buy | Buy |
Forward Estimates
| Period | EPS Est. | Revenue Est. | # Analysts |
|---|---|---|---|
| Fri Dec 31 | $6.55 | $4.47B | 14 |
| Sun Dec 31 | $7.59 | $4.84B | 13 |
| Mon Dec 31 | $8.42 | $5.12B | 11 |
| Tue Dec 31 | $9.11 | $5.39B | 5 |